Serum vascular endothelial growth factor as a marker of asthma exacerbation.
作者信息
Kim Joo-Hee
机构信息
Department of Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea.
出版信息
Korean J Intern Med. 2017 Mar;32(2):258-260. doi: 10.3904/kjim.2017.066. Epub 2017 Feb 28.
Abstract
摘要
相似文献
1
Serum vascular endothelial growth factor as a marker of asthma exacerbation.血清血管内皮生长因子作为哮喘急性加重的标志物。
Korean J Intern Med. 2017 Mar;32(2):258-260. doi: 10.3904/kjim.2017.066. Epub 2017 Feb 28.
2
Clinical significance of serum vascular endothelial growth factor in young male asthma patients.血清血管内皮生长因子在青年男性哮喘患者中的临床意义
Korean J Intern Med. 2017 Mar;32(2):295-301. doi: 10.3904/kjim.2014.242. Epub 2016 Mar 21.
3
[Vascular endothelial growth factor - structure, function and role in airways inflammation and the clinical course of asthma].[血管内皮生长因子——结构、功能及其在气道炎症和哮喘临床病程中的作用]
Pneumonol Alergol Pol. 2009;77(6):549-53.
4
Clinical significance of plasma and serum vascular endothelial growth factor in asthma.血浆和血清血管内皮生长因子在哮喘中的临床意义
J Asthma. 2008 Nov;45(9):735-9. doi: 10.1080/02770900802216775.
5
Vascular remodelling in asthma.哮喘中的血管重塑
Curr Opin Allergy Clin Immunol. 2008 Feb;8(1):39-43. doi: 10.1097/ACI.0b013e3282f42696.
6
Relationships of methacholine and adenosine monophosphate responsiveness with serum vascular endothelial growth factor in children with asthma.哮喘患儿乙酰甲胆碱和单磷酸腺苷反应性与血清血管内皮生长因子的关系。
Ann Allergy Asthma Immunol. 2010 Jan;104(1):36-41. doi: 10.1016/j.anai.2009.11.012.
7
Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma.血管内皮生长因子及其受体的基因表达与支气管哮喘中的血管生成
J Allergy Clin Immunol. 2001 Jun;107(6):1034-8. doi: 10.1067/mai.2001.115626.
8
Effects of academic exam stress on nasal leukotriene B4 and vascular endothelial growth factor in asthma and health.学术考试压力对哮喘患者及健康人群鼻腔白三烯B4和血管内皮生长因子的影响。
Biol Psychol. 2016 Jul;118:44-51. doi: 10.1016/j.biopsycho.2016.04.009. Epub 2016 Apr 30.
9
Increased expression of tissue vascular endothelial growth factor and foetal liver kinase-1 receptor in seasonal allergic rhinitis and relevance to asthma component.季节性变应性鼻炎中组织血管内皮生长因子和胎儿肝激酶-1受体表达增加及其与哮喘组分的相关性
Clin Exp Allergy. 2007 Aug;37(8):1183-8. doi: 10.1111/j.1365-2222.2007.02763.x.
10
Evaluation of angiopoietin 1 and 2, vascular endothelial growth factor, and tumor necrosis factor alpha levels in asthmatic children.哮喘儿童血管生成素1和2、血管内皮生长因子及肿瘤坏死因子α水平的评估
Allergy Asthma Proc. 2014 Nov-Dec;35(6):482-8. doi: 10.2500/aap.2014.35.3793.
引用本文的文献
1
The therapeutic potential of glucagon-like peptide-1 receptor analogs for neuroinflammation in the setting of asthma.胰高血糖素样肽-1受体类似物在哮喘背景下对神经炎症的治疗潜力。
Explor Asthma Allergy. 2025;3. doi: 10.37349/eaa.2025.100967. Epub 2024 Dec 17.
2
In-silico identification and prioritization of therapeutic targets of asthma.计算机辅助鉴定和优先考虑哮喘的治疗靶点。
Sci Rep. 2023 Sep 21;13(1):15706. doi: 10.1038/s41598-023-42803-w.
3
Urinary total conjugated 3-bromotyrosine, asthma severity, and exacerbation risk.尿总结合 3-溴酪氨酸、哮喘严重程度和恶化风险。
Am J Physiol Lung Cell Mol Physiol. 2022 Nov 1;323(5):L548-L557. doi: 10.1152/ajplung.00141.2022. Epub 2022 Sep 20.
4
Chronic allergic lung inflammation negatively influences neurobehavioral outcomes in mice.慢性过敏性肺部炎症会对小鼠的神经行为结果产生负面影响。
J Neuroinflammation. 2022 Aug 31;19(1):210. doi: 10.1186/s12974-022-02575-y.
5
Mechanism of Peitu Shengjin Formula Shenlingbaizhu Powder in Treating Bronchial Asthma and Allergic Colitis through Different Diseases with Simultaneous Treatment Based on Network Pharmacology and Molecular Docking.基于网络药理学和分子对接探讨培土生金方参苓白术散异病同治支气管哮喘和过敏性结肠炎的作用机制
Evid Based Complement Alternat Med. 2022 May 9;2022:4687788. doi: 10.1155/2022/4687788. eCollection 2022.
6
Vascular Endothelial Growth Factor as a Putative Biomarker of Depression in Asthmatics with Reversible Airway Narrowing.血管内皮生长因子作为可逆性气道狭窄哮喘患者抑郁的潜在生物标志物
J Clin Med. 2021 Nov 15;10(22):5301. doi: 10.3390/jcm10225301.
7
Emerging concepts and directed therapeutics for the management of asthma: regulating the regulators.哮喘管理的新观念和靶向治疗：调控调控因子。
Inflammopharmacology. 2021 Feb;29(1):15-33. doi: 10.1007/s10787-020-00770-y. Epub 2020 Nov 5.
本文引用的文献
1
The current and future role of biomarkers in type 2 cytokine-mediated asthma management.生物标志物在2型细胞因子介导的哮喘管理中的当前及未来作用。
Clin Exp Allergy. 2017 Feb;47(2):148-160. doi: 10.1111/cea.12881.
2
Development of New Therapies for Severe Asthma.重度哮喘新疗法的研发
Allergy Asthma Immunol Res. 2017 Jan;9(1):3-14. doi: 10.4168/aair.2017.9.1.3.
3
Clinical significance of serum vascular endothelial growth factor in young male asthma patients.血清血管内皮生长因子在青年男性哮喘患者中的临床意义
Korean J Intern Med. 2017 Mar;32(2):295-301. doi: 10.3904/kjim.2014.242. Epub 2016 Mar 21.
4
Analysis of growth factors in serum and induced sputum from patients with asthma.哮喘患者血清和诱导痰中生长因子的分析。
Exp Ther Med. 2014 Aug;8(2):573-578. doi: 10.3892/etm.2014.1759. Epub 2014 Jun 4.
5
Asthma exacerbations: origin, effect, and prevention.哮喘恶化：起源、影响和预防。
J Allergy Clin Immunol. 2011 Dec;128(6):1165-74. doi: 10.1016/j.jaci.2011.10.024.
6
Angiogenesis and lymphangiogenesis in bronchial asthma.支气管哮喘中的血管生成和淋巴管生成。
Allergy. 2010 Aug;65(8):946-58. doi: 10.1111/j.1398-9995.2010.02372.x. Epub 2010 Apr 23.
7
Angiogenesis in asthma.哮喘中的血管生成。
Clin Exp Allergy. 2009 Dec;39(12):1815-21. doi: 10.1111/j.1365-2222.2009.03385.x.
8
Clinical significance of plasma and serum vascular endothelial growth factor in asthma.血浆和血清血管内皮生长因子在哮喘中的临床意义
J Asthma. 2008 Nov;45(9):735-9. doi: 10.1080/02770900802216775.
9
Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer.体内的血管内皮生长因子（VEGF）在哪里？癌症中VEGF分布的荟萃分析。
Br J Cancer. 2007 Oct 8;97(7):978-85. doi: 10.1038/sj.bjc.6603923. Epub 2007 Oct 2.
10
Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis.血管重塑是哮喘和非哮喘性嗜酸性粒细胞性支气管炎的一个特征。
J Allergy Clin Immunol. 2007 Oct;120(4):813-9. doi: 10.1016/j.jaci.2007.05.028. Epub 2007 Jul 5.
Zotero 插件